A comparative study of cell cycle mediator protein expression patterns in anaplastic and papillary thyroid carcinoma

References

• Are C, Shaha AR. Anaplastic thyroid carcinoma: biology, pathogenesis, prognostic factors, and treatment approaches. Ann Surg Oncol 2006; 13:453 - 64; http://dx.doi.org/10.1245/ASO.2006.05.042; PMID: 16474910
   PubMed Web of Science ®Google Scholar
• Neff RL, Farrar WB, Kloos RT, Burman KD. Anaplastic thyroid cancer. Endocrinol Metab Clin North Am 2008; 37:525 - 38, xi; http://dx.doi.org/10.1016/j.ecl.2008.02.003; PMID: 18502341
   PubMed Web of Science ®Google Scholar
• Wiseman SM, Masoudi H, Niblock P, Turbin D, Rajput A, Hay J, et al. Anaplastic thyroid carcinoma: expression profile of targets for therapy offers new insights for disease treatment. Ann Surg Oncol 2007; 14:719 - 29; http://dx.doi.org/10.1245/s10434-006-9178-6; PMID: 17115102
   PubMed Web of Science ®Google Scholar
• Mitzer R, Goldenberg D, Durvesh S, Evans J. Anaplastic thyroid cancer: A three decade experience. [Abstract] Otolaryngol Head Neck Surg 2009; 141:144; http://dx.doi.org/10.1016/j.otohns.2009.06.459; PMID: 19559976
   PubMed Web of Science ®Google Scholar
• Lam KY, Lo CY, Chan KW, Wan KY. Insular and anaplastic carcinoma of the thyroid: a 45-year comparative study at a single institution and a review of the significance of p53 and p21. Ann Surg 2000; 231:329 - 38; http://dx.doi.org/10.1097/00000658-200003000-00005; PMID: 10714625
   PubMed Web of Science ®Google Scholar
• Wiseman SM, Loree TR, Rigual NR, Hicks WL Jr., Douglas WG, Anderson GR, et al. Anaplastic transformation of thyroid cancer: review of clinical, pathologic, and molecular evidence provides new insights into disease biology and future therapy. Head Neck 2003; 25:662 - 70; http://dx.doi.org/10.1002/hed.10277; PMID: 12884350
   PubMed Web of Science ®Google Scholar
• Saltman B, Singh B, Hedvat CV, Wreesmann VB, Ghossein R. Patterns of expression of cell cycle/apoptosis genes along the spectrum of thyroid carcinoma progression. Surgery 2006; 140:899 - 905, discussion 905-6; http://dx.doi.org/10.1016/j.surg.2006.07.027; PMID: 17188136
   PubMed Web of Science ®Google Scholar
• Melck A, Masoudi H, Griffith OL, Rajput A, Wilkins G, Bugis S, et al. Cell cycle regulators show diagnostic and prognostic utility for differentiated thyroid cancer. Ann Surg Oncol 2007; 14:3403 - 11; http://dx.doi.org/10.1245/s10434-007-9572-8; PMID: 17882495
   PubMed Web of Science ®Google Scholar
• Ensinger C, Spizzo G, Moser P, Tschoerner I, Prommegger R, Gabriel M, et al. Epidermal growth factor receptor as a novel therapeutic target in anaplastic thyroid carcinomas. Ann N Y Acad Sci 2004; 1030:69 - 77; http://dx.doi.org/10.1196/annals.1329.009; PMID: 15659782
   PubMed Web of Science ®Google Scholar
• Elliott DD, Sherman SI, Busaidy NL, Williams MD, Santarpia L, Clayman GL, et al. Growth factor receptors expression in anaplastic thyroid carcinoma: potential markers for therapeutic stratification. Hum Pathol 2008; 39:15 - 20; http://dx.doi.org/10.1016/j.humpath.2007.05.012; PMID: 17949783
   PubMed Web of Science ®Google Scholar
• Sugitani I, Kasai N, Fujimoto Y, Yanagisawa A. Prognostic factors and therapeutic strategy for anaplastic carcinoma of the thyroid. World J Surg 2001; 25:617 - 22; http://dx.doi.org/10.1007/s002680020166; PMID: 11369989
   PubMed Web of Science ®Google Scholar
• Aratake Y, Nomura H, Kotani T, Marutsuka K, Kobayashi K, Kuma K, et al. Coexistant anaplastic and differentiated thyroid carcinoma an immunohistochemical study. Am J Clin Pathol 2006; 125:399 - 406
   Web of Science ®Google Scholar
• Wang HM, Huang YW, Huang JS, Wang CH, Kok VC, Hung CM, et al. Anaplastic carcinoma of the thyroid arising more often from follicular carcinoma than papillary carcinoma. Ann Surg Oncol 2007; 14:3011 - 8; http://dx.doi.org/10.1245/s10434-007-9503-8; PMID: 17638058
   PubMed Web of Science ®Google Scholar
• Wiseman SM, Griffith OL, Deen S, Rajput A, Masoudi H, Gilks B, et al. Identification of molecular markers altered during transformation of differentiated into anaplastic thyroid carcinoma. Arch Surg 2007; 142:717 - 27, discussion 727-9; http://dx.doi.org/10.1001/archsurg.142.8.717; PMID: 17709725
   PubMed Web of Science ®Google Scholar
• Wiseman SM, Masoudi H, Niblock P, Turbin D, Rajput A, Hay J, et al. Derangement of the E-cadherin/catenin complex is involved in transformation of differentiated to anaplastic thyroid carcinoma. Am J Surg 2006; 191:581 - 7; http://dx.doi.org/10.1016/j.amjsurg.2006.02.005; PMID: 16647341
   PubMed Web of Science ®Google Scholar
• Quiros RM, Ding HG, Gattuso P, Prinz RA, Xu X. Evidence that one subset of anaplastic thyroid carcinomas are derived from papillary carcinomas due to BRAF and p53 mutations. Cancer 2005; 103:2261 - 8; http://dx.doi.org/10.1002/cncr.21073; PMID: 15880523
   PubMed Web of Science ®Google Scholar
• Montero-Conde C, Martín-Campos JM, Lerma E, Gimenez G, Martínez-Guitarte JL, Combalía N, et al. Molecular profiling related to poor prognosis in thyroid carcinoma. Combining gene expression data and biological information. Oncogene 2008; 27:1554 - 61; http://dx.doi.org/10.1038/sj.onc.1210792; PMID: 17873908
   PubMed Web of Science ®Google Scholar
• Elliott DD, Sherman SI, Busaidy NL, Williams MD, Santarpia L, Clayman GL, et al. Growth factor receptors expression in anaplastic thyroid carcinoma: potential markers for therapeutic stratification. Hum Pathol 2008; 39:15 - 20; http://dx.doi.org/10.1016/j.humpath.2007.05.012; PMID: 17949783
   PubMed Web of Science ®Google Scholar
• Mitsiades CS, Kotoula V, Poulaki V, Sozopoulos E, Negri J, Charalambous E, et al. Epidermal growth factor receptor as a therapeutic target in human thyroid carcinoma: mutational and functional analysis. J Clin Endocrinol Metab 2006; 91:3662 - 6; http://dx.doi.org/10.1210/jc.2006-0055; PMID: 16822827
   PubMed Web of Science ®Google Scholar
• Lee DH, Lee GK, Kong SY, Kook MC, Yang SK, Park SY, et al. Epidermal growth factor receptor status in anaplastic thyroid carcinoma. J Clin Pathol 2007; 60:881 - 4; http://dx.doi.org/10.1136/jcp.2006.041251; PMID: 17079354
   PubMed Web of Science ®Google Scholar
• Ulisse S, Delcros JG, Baldini E, Toller M, Curcio F, Giacomelli L, et al. Expression of Aurora kinases in human thyroid carcinoma cell lines and tissues. Int J Cancer 2006; 119:275 - 82; http://dx.doi.org/10.1002/ijc.21842; PMID: 16477625
   PubMed Web of Science ®Google Scholar
• Sorrentino R, Libertini S, Pallante PL, Troncone G, Palombini L, Bavetsias V, et al. Aurora B overexpression associates with the thyroid carcinoma undifferentiated phenotype and is required for thyroid carcinoma cell proliferation. J Clin Endocrinol Metab 2005; 90:928 - 35; http://dx.doi.org/10.1210/jc.2004-1518; PMID: 15562011
   PubMed Web of Science ®Google Scholar